Suppr超能文献

多焦点人工晶状体植入术后的再次治疗:一项分析

Retreatments after multifocal intraocular lens implantation: an analysis.

作者信息

Gundersen Kjell Gunnar, Makari Sarah, Ostenstad Steffen, Potvin Rick

机构信息

Ifocus Eye Clinic, Haugesund, Norway.

Science in Vision, Akron, NY, USA.

出版信息

Clin Ophthalmol. 2016 Mar 1;10:365-71. doi: 10.2147/OPTH.S100840. eCollection 2016.

Abstract

PURPOSE

To determine the incidence and etiology of required retreatment after multifocal intraocular lens (IOL) implantation and to evaluate the methods and clinical outcomes of retreatment.

PATIENTS AND METHODS

A retrospective chart review of 416 eyes of 209 patients from one site that underwent uncomplicated cataract surgery with multifocal IOL implantation. Biometry, the IOL, and refractive data were recorded after the original implantation, with the same data recorded after retreatment. Comments related to vision were obtained both before and after retreatment for retreated patients.

RESULTS

The multifocal retreatment rate was 10.8% (45/416 eyes). The eyes that required retreatment had significantly higher residual refractive astigmatism compared with those who did not require retreatment (1.21±0.51 D vs 0.51±0.39 D, P<0.01). The retreatment rate for the two most commonly implanted primary IOLs, blended bifocal (10.5%, 16/152) and bilateral trifocal (6.9%, 14/202) IOLs, was not statistically significantly different (P=0.12). In those requiring retreatment, refractive-related complaints were most common. Retreatment with refractive corneal surgery, in 11% of the eyes, and piggyback IOLs, in 89% of the eyes, was similarly successful, improving patient complaints 78% of the time.

CONCLUSION

Complaints related to ametropia were the main reasons for retreatment. Residual astigmatism appears to be an important determinant of retreatment rate after multifocal IOL implantation. Retreatment can improve symptoms for a high percentage of patients; a piggyback IOL is a viable retreatment option.

摘要

目的

确定多焦点人工晶状体(IOL)植入术后所需再次治疗的发生率和病因,并评估再次治疗的方法和临床结果。

患者和方法

对来自一个地点的209例患者的416只眼进行回顾性病历审查,这些患者接受了无并发症的白内障手术并植入了多焦点IOL。在初次植入后记录生物测量、IOL和屈光数据,再次治疗后记录相同的数据。对接受再次治疗的患者,在再次治疗前后均获取与视力相关的评价。

结果

多焦点再次治疗率为10.8%(45/416只眼)。需要再次治疗的眼与不需要再次治疗的眼相比,残余屈光性散光明显更高(1.21±0.51 D对0.51±0.39 D,P<0.01)。两种最常用的初次植入IOL,即混合双焦点(10.5%,16/152)和双侧三焦点(6.9%,14/202)IOL的再次治疗率在统计学上无显著差异(P = 0.12)。在需要再次治疗的患者中,屈光相关的主诉最为常见。11%的眼采用屈光性角膜手术进行再次治疗,89%的眼采用附加IOL进行再次治疗,同样取得了成功,78%的时间改善了患者的主诉。

结论

与屈光不正相关的主诉是再次治疗的主要原因。残余散光似乎是多焦点IOL植入术后再次治疗率的重要决定因素。再次治疗可以使高比例患者的症状得到改善;附加IOL是一种可行的再次治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e3/4780184/e6afd22e3e31/opth-10-365Fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验